Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata has a high chance of persisting and relapsing, with a significant risk of total hair loss, especially if it starts in childhood.

SARMs work differently in tissues due to unique interactions and structures.

The guideline provides recommendations for managing alopecia areata effectively.

Certain gene variations might increase the risk of a hair loss condition in Koreans.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

Analog 23 is a promising compound for prostate cancer treatment.

The study found that combining different databases gives a better estimate of drug side effects in hospitals.

Alpha-hydroxy acids, like glycolic acid, safely improve skin issues and work on all skin types.

Blocking the CCR5 receptor may be a new way to treat hair loss from alopecia areata.

Many patients with Alopecia Areata have underlying autoimmune disorders, especially thyroid issues.

PPAR β/δ is important for skin health and disease treatment, but more research is needed.

Anti-PD-L1 immunotherapy can cause hair loss and unexpected hair color change, but treatment can restore hair growth and color.

A genetic test can identify people at risk of male pattern baldness early, allowing for quicker treatment.

GLP-1 receptor agonists can help manage PCOS metabolism but need careful use before conception.

Understanding snoRNA regulation may help slow skin aging.

Recognizing IPPP is crucial to prevent misdiagnosis and unnecessary treatments.

Some prostate cancers have gene changes that may affect treatment with certain drugs.

New genetic mutations causing hair loss were found in a Chinese family.

JAK-inhibitors for alopecia areata are generally safe with mostly mild side effects and a low rate of treatment withdrawal.

Platelet Rich Plasma can potentially help in restoring hair loss, but more research with larger groups is needed to confirm its effectiveness and standardize its use.

PP405 shows promise as a new, effective treatment for hair loss with minimal side effects.

Platelet-rich plasma injections can effectively treat alopecia areata barbae.

SPARC likely aids in tissue remodeling during the hair cycle, not in starting new hair growth phases.

Shorter GGN repeats in the androgen receptor gene are linked to androgenetic alopecia.

PUVA treatment led to significant hair regrowth in over half of the patients with alopecia areata totalis and universalis.

Prescriptions for 5-alpha reductase inhibitors dropped significantly after the FDA's safety warning, especially for men with benign prostatic hyperplasia.

Alopecia areata greatly affects people's life quality, mental health, and work life.

Everyone has an immune response to PPD, but reactions differ, causing tolerance, mild inflammation, or allergy.

The new anti-acne treatment HA-P5 effectively reduces acne by targeting two key receptors and avoids an enzyme that can hinder treatment.

GLP-1RA therapy may increase the risk of hair loss.